Top

Published in:

01-10-2011 | Review

The side effects of phototherapy for neonatal jaundice: what do we know? What should we do?

Authors: Tao Xiong, Yi Qu, Stephanie Cambier, Dezhi Mu

Published in: European Journal of Pediatrics | Issue 10/2011

Abstract

Neonatal phototherapy (NNPT), a noninvasive, easily available therapy, has been widely used for the treatment of neonatal jaundice for more than half a century. Its efficiency in decreasing plasma bilirubin concentration is well documented, and NNPT leads to greatly reduced exchange transfusion rates for neonates with hyperbilirubinemia. It is generally accepted that the side effects of NNPT are not serious and seem to be well controlled. This review will focus on these possible side effects as well as the approaches to minimize them.

Abrol P, Sankarasubramanian R (1998) Effect of phototherapy on behaviour of jaundiced neonates. Indian J Pediatr 65:603–607PubMedCrossRef

Ahlfors CE (2010) Predicting bilirubin neurotoxicity in jaundiced newborns. Curr Opin Pediatr 22:129–133PubMedCrossRef

Ahlfors CE, Amin SB, Parker AE (2009) Unbound bilirubin predicts abnormal automated auditory brainstem response in a diverse newborn population. J Perinatol 29:305–309PubMedCrossRef

Ahlfors CE, Parker AE (2008) Unbound bilirubin concentration is associated with abnormal automated auditory brainstem response for jaundiced newborns. Pediatrics 121:976–978PubMedCrossRef

Ahlfors CE, Wennberg RP, Ostrow JD, Tiribelli C (2009) Unbound (free) bilirubin: improving the paradigm for evaluating neonatal jaundice. Clin Chem 55:1288–1299PubMedCrossRef

Ambach A, Bonnekoh B, Gollnick H (2006) UVA1 radiation (340–400 nm) interferes with the perforin-granule system of CD8hi + cytotoxic T lymphocytes in vitro. J Photochem Photobiol B 82:236–243PubMedCrossRef

American Academy of Pediatrics Subcommittee on Hyperbilirubinemia (2004) Management of hyperbilirubinemia in the newborn infant 35 or more weeks of gestation. Pediatrics 114:297–316CrossRef

Arya VB, Agarwal R, Paul VK, Deorari AK (2004) Efficacy of oral phenobarbitone in term “at risk” neonates in decreasing neonatal hyperbilirubinemia: a randomized double-blinded, placebo controlled trial. Indian Pediatr 41:327–332PubMed

Aspberg S, Dahlquist G, Kahan T, Kallen B (2007) Is neonatal phototherapy associated with an increased risk for hospitalized childhood bronchial asthma? Pediatr Allergy Immunol 18:313–319PubMedCrossRef

10.

Aspberg S, Dahlquist G, Kahan T, Kallen B (2010) Confirmed association between neonatal phototherapy or neonatal icterus and risk of childhood asthma. Pediatr Allergy Immunol 21:e733–e739PubMedCrossRef

11.

Aycicek A, Erel O (2007) Total oxidant/antioxidant status in jaundiced newborns before and after phototherapy. J Pediatr (Rio J) 83:319–322

12.

Aycicek A, Kocyigit A, Erel O, Senturk H (2008) Phototherapy causes DNA damage in peripheral mononuclear leukocytes in term infants. J Pediatr (Rio J) 84:141–146CrossRef

13.

Baba L, McGrath JM (2008) Oxygen free radicals: effects in the newborn period. Adv Neonatal Care 8:256–264PubMed

14.

Bader D, Kugelman A, Blum DE et al (2006) Effect of phototherapy on cardiorespiratory activity during sleep in neonates with physiologic jaundice. Isr Med Assoc J 8:12–16PubMed

15.

Barefield ES, Dwyer MD, Cassady G (1993) Association of patent ductus arteriosus and phototherapy in infants weighing less than 1000 grams. J Perinatol 13:376–380PubMed

16.

Basiglio CL, Arriaga SM, Pelusa F et al (2010) Complement activation and disease: protective effects of hyperbilirubinaemia. Clin Sci (Lond) 118:99–113CrossRef

17.

Batenburg WW, Kappers MH, Eikmann MJ et al (2009) Light-induced vs. bradykinin-induced relaxation of coronary arteries: do S-nitrosothiols act as endothelium-derived hyperpolarizing factors? J Hypertens 27:1631–1640PubMedCrossRef

18.

Bauer J, Buttner P, Luther H et al (2004) Blue light phototherapy of neonatal jaundice does not increase the risk for melanocytic nevus development. Arch Dermatol 140:493–494PubMedCrossRef

19.

Benders MJ, Van Bel F, Van de Bor M (1999) Cardiac output and ductal reopening during phototherapy in preterm infants. Acta Paediatr 88:1014–1019PubMedCrossRef

20.

Berg P, Lindelof B (1997) Is phototherapy in neonates a risk factor for malignant melanoma development? Arch Pediatr Adolesc Med 151:1185–1187PubMed

21.

Bertini G, Dani C, Fonda C et al (2005) Bronze baby syndrome and the risk of kernicterus. Acta Paediatr 94:968–971PubMedCrossRef

22.

Bhutani VK, Maisels MJ, Stark AR, Buonocore G (2008) Management of jaundice and prevention of severe neonatal hyperbilirubinemia in infants > or = 35 weeks gestation. Neonatology 94:63–67PubMedCrossRef

23.

Bjorksten B (2008) Environmental influences on the development of the immune system: consequences for disease outcome. Nestle Nutr Workshop Ser Pediatr Program 61:243–254PubMedCrossRef

24.

Boo NY, Chew EL (2006) A randomised control trial of clingfilm for prevention of hypothermia in term infants during phototherapy. Singapore Med J 47:757–762PubMed

25.

Brewster DH, Tucker JS, Fleming M et al (2010) Risk of skin cancer after neonatal phototherapy: retrospective cohort study. Arch Dis Child 95:826–831PubMedCrossRef

26.

Bryla DA (1985) Randomized, controlled trial of phototherapy for neonatal hyperbilirubinemia. Development, design, and sample composition. Pediatrics 75:387–392PubMed

27.

Canadian Paediatric Society (2007) Guidelines for detection, management and prevention of hyperbilirubinemia in term and late preterm newborn infants (35 or more weeks' gestation)—summary. Paediatr Child Health 12:401–418

28.

Chen A, Du L, Xu Y et al (2005) The effect of blue light exposure on the expression of circadian genes: bmal1 and cryptochrome 1 in peripheral blood mononuclear cells of jaundiced neonates. Pediatr Res 58:1180–1184PubMedCrossRef

29.

Csoma Z, Hencz P, Orvos H et al (2007) Neonatal blue-light phototherapy could increase the risk of dysplastic nevus development. Pediatrics 119:1036–1037, author reply 1037–1038PubMedCrossRef

30.

Csoma Z, Hencz P, Orvos H et al (2007) Neonatal blue-light phototherapy could increase the risk of dysplastic nevus development. Pediatrics 119:1269PubMedCrossRef

31.

Csoma Z, Kemeny L, Olah J (2008) Phototherapy for neonatal jaundice. N Engl J Med 358:2523–2524, author reply 2524–2525PubMed

32.

De Luca D (2010) NICE guidelines on neonatal jaundice: at risk of being too nice. Lancet 376:771PubMedCrossRef

33.

De Luca D, Picone S, Fabiano A, Paolillo P (2010) Images in neonatal medicine. Bronze baby syndrome: pictorial description of a rare condition. Arch Dis Child Fetal Neonatal Ed 95:F325PubMedCrossRef

34.

Dennery PA (2002) Pharmacological interventions for the treatment of neonatal jaundice. Semin Neonatol 7:111–119PubMedCrossRef

35.

Dijk PH, de Vries TW, de Beer JJ (2009) Guideline ‘Prevention, diagnosis and treatment of hyperbilirubinemia in the neonate with a gestational age of 35 or more weeks’. Ned Tijdschr Geneeskd 153:A93PubMed

36.

Dobson V (1976) Editorial: phototherapy and retinal damage. Invest Ophthalmol 15:595–598PubMed

37.

Ebrahim M, Ahmad RS, Mohammad M (2010) Incidence and risk factors of retinopathy of prematurity in Babol, north of Iran. Ophthalmic Epidemiol 17:166–170PubMedCrossRef

38.

Eghbalian F, Monsef A (2002) Phototherapy-induced hypocalcemia in icteric newborns. Iran J Med Sci 27:169–171

39.

Gleissner MW, Spantzel T, Bucker-Nott HJ, Jorch G (2003) Risk factors of retinopathy of prematurity in infants 32 to 36 weeks gestational age. Z Geburtshilfe Neonatol 207:24–28PubMedCrossRef

40.

Gloria-Bottini F, Bottini E (2010) Is there a role of early neonatal events in susceptibility to allergy? Int J Biomed Sci 6:8–12

41.

Grimm C, Wenzel A, Williams T et al (2001) Rhodopsin-mediated blue-light damage to the rat retina: effect of photoreversal of bleaching. Invest Ophthalmol Vis Sci 42:497–505PubMed

42.

Hansen TW (2010) Twists and turns in phototherapy for neonatal jaundice. Acta Paediatr 99:1117–1118PubMedCrossRef

43.

Hooman N, Honarpisheh A (2005) The effect of phototherapy on urinary calcium excretion in newborns. Pediatr Nephrol 20:1363–1364PubMedCrossRef

44.

Horn AR, Kirsten GF, Kroon SM et al (2006) Phototherapy and exchange transfusion for neonatal hyperbilirubinaemia: neonatal academic hospitals’ consensus guidelines for South African hospitals and primary care facilities. S Afr Med J 96:819–824PubMed

45.

Ju SH, Lin CH (1991) The effect of moderate non-hemolytic jaundice and phototherapy on newborn behavior. Zhonghua Min Guo Xiao Er Ke Yi Xue Hui Za Zhi 32:31–41PubMed

46.

Juzeniene A, Setlow R, Porojnicu A et al (2009) Development of different human skin colors: a review highlighting photobiological and photobiophysical aspects. J Photochem Photobiol B 96:93–100PubMedCrossRef

47.

Karadag A, Yesilyurt A, Unal S et al (2009) A chromosomal-effect study of intensive phototherapy versus conventional phototherapy in newborns with jaundice. Mutat Res 676:17–20PubMed

48.

Karamifar H, Pishva N (2002) Prevalence of phototherapy-induced hypocalcemia. Iran J Med Sci 27:166–168

49.

Kernt M, Hirneiss C, Neubauer AS et al (2010) Protective effect of blue light-absorbing IOLs on the human retinal pigment epithelium. Ophthalmologe 107:150–157PubMedCrossRef

50.

Kernt M, Neubauer AS, Liegl R et al (2009) Cytoprotective effects of a blue light-filtering intraocular lens on human retinal pigment epithelium by reducing phototoxic effects on vascular endothelial growth factor-alpha, Bax, and Bcl-2 expression. J Cataract Refract Surg 35:354–362PubMedCrossRef

51.

Keshavan P, Deem TL, Schwemberger SJ et al (2005) Unconjugated bilirubin inhibits VCAM-1-mediated transendothelial leukocyte migration. J Immunol 174:3709–3718PubMed

52.

Khatami SF, Yousefi A, Bayat GF, Mamuri G (2008) Retinopathy of prematurity among 1000–2000 gram birth weight newborn infants. Iran J Pediatr 18:137–142

53.

King A, Gottlieb E, Brooks DG et al (2004) Mitochondria-derived reactive oxygen species mediate blue light-induced death of retinal pigment epithelial cells. Photochem Photobiol 79:470–475PubMedCrossRef

54.

Kumar A, Pant P, Basu S et al (2007) Oxidative stress in neonatal hyperbilirubinemia. J Trop Pediatr 53:69–71PubMedCrossRef

55.

Kumar P, Murki S, Malik GK et al (2010) Light emitting diodes versus compact fluorescent tubes for phototherapy in neonatal jaundice: a multi center randomized controlled trial. Indian Pediatr 47:131–137PubMedCrossRef

56.

Kurt A, Aygun AD, Kurt AN et al (2009) Use of phototherapy for neonatal hyperbilirubinemia affects cytokine production and lymphocyte subsets. Neonatology 95:262–266PubMedCrossRef

57.

Leiter U, Garbe C (2008) Epidemiology of melanoma and nonmelanoma skin cancer—the role of sunlight. Adv Exp Med Biol 624:89–103PubMedCrossRef

58.

Liu GS, Wu H, Wu BQ et al (2008) Effect of phototherapy on blood endothelin and nitric oxide levels: clinical significance in preterm infants. World J Pediatr 4:31–35PubMedCrossRef

59.

Luna MS, Alonso CR, Mussons FB et al (2009) Recommendations for the care of the healthy normal newborn at delivery and during the first postnatal hours. An Pediatr (Barc) 71:349–361CrossRef

60.

Maayan-Metzger A, Yosipovitch G, Hadad E, Sirota L (2001) Transepidermal water loss and skin hydration in preterm infants during phototherapy. Am J Perinatol 18:393–396PubMedCrossRef

61.

Maisels MJ, Kring EA, DeRidder J (2007) Randomized controlled trial of light-emitting diode phototherapy. J Perinatol 27:565–567PubMedCrossRef

62.

Maisels MJ, McDonagh AF (2008) Phototherapy for neonatal jaundice. N Engl J Med 358:920–928PubMedCrossRef

63.

Matichard E, Le Henanff A, Sanders A et al (2006) Effect of neonatal phototherapy on melanocytic nevus count in children. Arch Dermatol 142:1599–1604PubMedCrossRef

64.

Maverakis E, Miyamura Y, Bowen MP et al (2010) Light, including ultraviolet. J Autoimmun 34:J247–J257PubMedCrossRef

65.

McDonagh AF (2011) Bilirubin, copper-porphyrins, and the bronze-baby syndrome. J Pediatr 158:160–164PubMedCrossRef

66.

Mehta S, Kumar P, Narang A (2005) A randomized controlled trial of fluid supplementation in term neonates with severe hyperbilirubinemia. J Pediatr 147:781–785PubMedCrossRef

67.

Mills JF, Tudehope D (2001) Fibreoptic phototherapy for neonatal jaundice. Cochrane Database Syst Rev CD002060

68.

Moll M, Goelz R, Naegele T et al (2010) Are recommended phototherapy thresholds safe enough for extremely low birth weight (ELBW) infants? A report on 2 ELBW infants with kernicterus despite only moderate hyperbilirubinemia. Neonatology 99:90–94PubMedCrossRef

69.

Morris BH, Oh W, Tyson JE et al (2008) Aggressive vs. conservative phototherapy for infants with extremely low birth weight. N Engl J Med 359:1885–1896PubMedCrossRef

70.

Murki S, Dutta S, Narang A et al (2005) A randomized, triple-blind, placebo-controlled trial of prophylactic oral phenobarbital to reduce the need for phototherapy in G6PD-deficient neonates. J Perinatol 25:325–330PubMedCrossRef

71.

Neill WA, Halliday KE, Norval M (1998) Differential effect of phototherapy on the activities of human natural killer cells and cytotoxic T cells. J Photochem Photobiol B 47:129–135PubMedCrossRef

72.

Parra EJ (2007) Human pigmentation variation: evolution, genetic basis, and implications for public health. Am J Phys Anthropol 45:85–105PubMedCrossRef

73.

Procianoy RS, Silveira RC, Fonseca LT et al (2010) The influence of phototherapy on serum cytokine concentrations in newborn infants. Am J Perinatol 27:375–379PubMedCrossRef

74.

Rennie J, Burman-Roy S, Murphy MS (2010) Neonatal jaundice: summary of NICE guidance. BMJ 340:c2409PubMedCrossRef

75.

Rennie JM, Sehgal A, De A et al (2009) Range of UK practice regarding thresholds for phototherapy and exchange transfusion in neonatal hyperbilirubinaemia. Arch Dis Child Fetal Neonatal Ed 94:F323–F327PubMedCrossRef

76.

Rosenfeld W, Sadhev S, Brunot V et al (1986) Phototherapy effect on the incidence of patent ductus arteriosus in premature infants: prevention with chest shielding. Pediatrics 78:10–14PubMed

77.

Rubaltelli FF, Jori G, Reddi E (1983) Bronze baby syndrome: a new porphyrin-related disorder. Pediatr Res 17:327–330PubMedCrossRef

78.

Seidman DS, Moise J, Ergaz Z et al (2000) A new blue light-emitting phototherapy device: a prospective randomized controlled study. J Pediatr 136:771–774PubMedCrossRef

79.

Seidman DS, Moise J, Ergaz Z et al (2003) A prospective randomized controlled study of phototherapy using blue and blue-green light-emitting devices, and conventional halogen-quartz phototherapy. J Perinatol 23:123–127PubMedCrossRef

80.

Sharafi R, Mortazavi Z, Sharafi S, Parashkouh R (2010) The effect of clofibrate on decreasing serum bilirubin in healthy term neonates under home phototherapy. Iran J Pediatr 20:48–52

81.

Siegfried EC, Stone MS, Madison KC (1992) Ultraviolet light burn: a cutaneous complication of visible light phototherapy of neonatal jaundice. Pediatr Dermatol 9:278–282PubMedCrossRef

82.

Sola A (2007) Turn off the lights and the oxygen, when not needed: phototherapy and oxidative stress in the neonate. J Pediatr (Rio J) 83:293–296CrossRef

83.

Stevenson DK, Wong RJ (2010) Metalloporphyrins in the management of neonatal hyperbilirubinemia. Semin Fetal Neonatal Med 15:164–168PubMedCrossRef

84.

Stokowski LA (2006) Fundamentals of phototherapy for neonatal jaundice. Adv Neonatal Care 6:303–312PubMedCrossRef

85.

Tatli MM, Minnet C, Kocyigit A, Karadag A (2008) Phototherapy increases DNA damage in lymphocytes of hyperbilirubinemic neonates. Mutat Res 654:93–95PubMed

86.

Tobin AM, Maguire B, Enright H, Kirby B (2009) The effects of phototherapy on the numbers of circulating natural killer cells and T lymphocytes in psoriasis. Photodermatol Photoimmunol Photomed 25:109–110PubMedCrossRef

87.

Travadi J, Simmer K, Ramsay J et al (2006) Patent ductus arteriosus in extremely preterm infants receiving phototherapy: does shielding the chest make a difference? A randomized, controlled trial. Acta Paediatr 95:1418–1423PubMedCrossRef

88.

Usatin D, Liljestrand P, Kuzniewicz MW et al (2010) Effect of neonatal jaundice and phototherapy on the frequency of first-year outpatient visits. Pediatrics 125:729–734PubMedCrossRef

89.

van Imhoff DE, Dijk PH, Hulzebos CV (2009) Uniform intervention criteria for jaundice in hyperbilirubinemia in preterm infants. Ned Tijdschr Geneeskd 153:A94PubMed

90.

Varsila E, Pitkanen O, Hallman M, Andersson S (1994) Immaturity-dependent free radical activity in premature infants. Pediatr Res 36:55–59PubMedCrossRef

91.

Venturini CM, Palmer RM, Moncada S (1993) Vascular smooth muscle contains a depletable store of a vasodilator which is light-activated and restored by donors of nitric oxide. J Pharmacol Exp Ther 266:1497–1500PubMed

92.

Vreman HJ (2010) Phototherapy: the challenge to accurately measure irradiance. Indian Pediatr 47:127–128PubMedCrossRef

93.

Vreman HJ, Wong RJ, Murdock JR, Stevenson DK (2008) Standardized bench method for evaluating the efficacy of phototherapy devices. Acta Paediatr 97:308–316PubMedCrossRef

94.

Vreman HJ, Wong RJ, Stevenson DK et al (1998) Light-emitting diodes: a novel light source for phototherapy. Pediatr Res 44:804–809PubMedCrossRef

95.

Wales JK, Walker V, Moore IE, Clayton PT (1986) Bronze baby syndrome, biliary hypoplasia, incomplete Beckwith–Wiedemann syndrome and partial trisomy 11. Eur J Pediatr 145:141–143PubMedCrossRef

96.

Walsh SA, Murphy JF (2010) Neonatal jaundice—are we over-treating? Ir Med J 103:28–29PubMed

97.

Watchko JF, Jeffrey Maisels M (2010) Enduring controversies in the management of hyperbilirubinemia in preterm neonates. Semin Fetal Neonatal Med 15:136–140PubMedCrossRef

98.

Weissman A, Berkowitz E, Smolkin T, Blazer S (2009) Effect of phototherapy on neonatal heart rate variability and complexity. Neonatology 95:41–46PubMedCrossRef

99.

Wennberg RP, Ahlfors CE, Aravkin AY (2009) Intervention guidelines for neonatal hyperbilirubinemia: an evidence based quagmire. Curr Pharm Des 15:2939–2945PubMedCrossRef

100.

Whitelaw A, Odd D (2007) Postnatal phenobarbital for the prevention of intraventricular hemorrhage in preterm infants. Cochrane Database Syst Rev CD001691

101.

Yeo KL, Perlman M, Hao Y, Mullaney P (1998) Outcomes of extremely premature infants related to their peak serum bilirubin concentrations and exposure to phototherapy. Pediatrics 102:1426–1431PubMedCrossRef

102.

Zecca E, Romagnoli C, De Carolis MP et al (2009) Does ibuprofen increase neonatal hyperbilirubinemia? Pediatrics 124:480–484PubMedCrossRef

Title: The side effects of phototherapy for neonatal jaundice: what do we know? What should we do?
Authors: Tao Xiong
Yi Qu
Stephanie Cambier
Dezhi Mu
Publication date: 01-10-2011
Publisher: Springer-Verlag
Published in: European Journal of Pediatrics / Issue 10/2011
Print ISSN: 0340-6199
Electronic ISSN: 1432-1076
DOI: https://doi.org/10.1007/s00431-011-1454-1

Keynote webinar | Spotlight on medication adherence

Springer Medicine

The side effects of phototherapy for neonatal jaundice: what do we know? What should we do?

Abstract

Keynote webinar | Spotlight on medication adherence

Springer Medicine

Abstract

Please log in to get access to this content

Other articles of this Issue 10/2011

Lipoprotein lipase gene polymorphisms and risks of childhood obesity in Chinese preschool children

Nocturnal apnea in Chiari type I malformation

PHOX2B mutations in patients with Ondine–Hirschsprung disease and a review of the literature

Haemodynamically unstable preterm infant: an unresolved management conundrum

Tetrasomy and pentasomy of the X chromosome

Clinical practice